with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Industry

CPC
C07D237/32

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07DHETEROCYCLIC COMPOUNDS C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

Current Industry

C07D237/32with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Industries

Patents Grantslast 30 patents

Information Patent Grant
Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione
- Patent number 12,122,753
- Issue date Oct 22, 2024
- MetrioPharm AG
- Ingo Saar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compound
- Patent number 12,071,434
- Issue date Aug 27, 2024
- Takeda Pharmaceutical Company Limited
- Yuhei Miyanohana
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Olaparib hydroxybenzoic acid cocrystals and their pharmaceutical use
- Patent number 12,049,452
- Issue date Jul 30, 2024
- NUFORMIX TECHNOLOGIES LIMITED
- Joanne Holland
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Olaparib oxalic acid cocrystals and their pharmaceutical use
- Patent number 12,012,386
- Issue date Jun 18, 2024
- NUFORMIX TECHNOLOGIES LIMITED
- Joanne Holland
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-cancer nuclear hormone receptor-targeting compounds
- Patent number 11,952,349
- Issue date Apr 9, 2024
- NUVATION BIO INC.
- Son Minh Pham
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Low affinity poly(AD-ribose) polymerase 1 dependent cytotoxic agents
- Patent number 11,542,282
- Issue date Jan 3, 2023
- The Trustees of the University of Pennsylvania
- Robert H. Mach
- G01 - MEASURING TESTING
Information Patent Grant
MTA-cooperative PRMT5 inhibitors
- Patent number 11,492,351
- Issue date Nov 8, 2022
- Mirati Therapeutics, Inc.
- Thomas P. Bobinski
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
MTA-cooperative PRMT5 inhibitors
- Patent number 11,479,551
- Issue date Oct 25, 2022
- Mirati Therapeutics, Inc.
- Thomas P. Bobinski
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Labile esters of agrochemicals for controlled release and reduction...
- Patent number 11,465,960
- Issue date Oct 11, 2022
- Monsanto Technology LLC
- David A. Morgenstern
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Pyridinones and isoquinolinones as inhibitors of the bromodomain BRD9
- Patent number 11,319,318
- Issue date May 3, 2022
- Boehringer Ingelheim International GmbH
- Laetitia Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methhod for producing a crystalline form of 5-amino-2,3-dihydrophth...
- Patent number 11,203,575
- Issue date Dec 21, 2021
- MetrioPharm AG
- Thomas Martin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonists of human integrin (α4)(β7)
- Patent number 11,174,228
- Issue date Nov 16, 2021
- Morphic Therapeutic, Inc.
- Matthew G. Bursavich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phthalazinone derivatives
- Patent number 11,160,803
- Issue date Nov 2, 2021
- KuDos Pharmaceuticals Limited
- Niall Morrison Barr Martin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for measuring tyrosine phosphatase and tyrosine kinase activity
- Patent number 11,119,095
- Issue date Sep 14, 2021
- Tokyo Institute of Technology
- Shinichi Sato
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione
- Patent number 11,111,218
- Issue date Sep 7, 2021
- MetrioPharm AG
- Thomas Martin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PRMT5 inhibitors
- Patent number 10,961,256
- Issue date Mar 30, 2021
- CTXT PTY. LTD.
- Paul Anthony Stupple
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phthalazinone compounds and methods for the treatment of cystic fib...
- Patent number 10,889,576
- Issue date Jan 12, 2021
- Flatley Discovery Lab, LLC
- Bridget M. Cole
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Labile esters of agrochemicals for controlled release and reduction...
- Patent number 10,793,503
- Issue date Oct 6, 2020
- Monsanto Technology LLC
- David A. Morgenstern
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antagonists of human integrin α4β7
- Patent number 10,759,756
- Issue date Sep 1, 2020
- Morphic Therapeutic, Inc.
- Matthew G. Bursavich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of olaparib and a process for preparing the same
- Patent number 10,703,728
- Issue date Jul 7, 2020
- ScinoPharm Taiwan, Ltd.
- Wen-Wei Lin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polyhydroxyphthalazinone compound, preparation method thereof and u...
- Patent number 10,640,469
- Issue date May 5, 2020
- RejuvGen Pharmaceuticals, Inc.
- Faxiang Liang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Radiohalide-labeled targeted diagnostics and therapeutics
- Patent number 10,512,700
- Issue date Dec 24, 2019
- Memorial Sloan Kettering Cancer Center
- Thomas Reiner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cardiac troponin I ultra-sensitive detection reagent kit, and ultra...
- Patent number 10,472,400
- Issue date Nov 12, 2019
- SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD
- Wei Rao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phthalazinone derivatives
- Patent number 10,449,192
- Issue date Oct 22, 2019
- KUDO PHARMACEUTICALS LIMITED
- Niall Morrison Barr Martin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phthalazinones and isoquinolinones as rock inhibitors
- Patent number 10,385,026
- Issue date Aug 20, 2019
- Bristol-Myers Squibb Company
- Peter W. Glunz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridazinone compounds and methods for the treatment of cystic fibr...
- Patent number 10,370,366
- Issue date Aug 6, 2019
- Flatley Discovery Lab, LLC
- Bridget M. Cole
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitor compounds of phosphodiesterase type 10A
- Patent number 10,308,610
- Issue date Jun 4, 2019
- AbbVie Deutschland GmbH and Co KG
- Hervé Geneste
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phthalazinone compounds and methods for the treatment of cystic fib...
- Patent number 10,280,160
- Issue date May 7, 2019
- Flatley Discovery Lab, LLC
- Bridget M. Cole
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium...
- Patent number 10,258,620
- Issue date Apr 16, 2019
- MetrioPharm AG
- Thomas Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,4-dioxo-quinazoline-6-sulfonamide derivatives as inhibitors of PARG
- Patent number 10,239,843
- Issue date Mar 26, 2019
- Cancer Research Technology Limited
- Alison E. McGonagle
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE
- Publication number 20240374589
- Publication date Nov 14, 2024
- Soley Therapeutics, Inc.
- Nadia Mamoona AHMAD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR THE PREPARATION OF OLAPARIB, AND CRYSTALLINE FORM THEREOF
- Publication number 20240351989
- Publication date Oct 24, 2024
- Glenmark Life Sciences Limited
- Venkata Raghavendra Charyulu PALLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED HETEROBICYCLIC DERIVATIVES AS NEGATIVE ALLOSTERIC MODUL...
- Publication number 20240327375
- Publication date Oct 3, 2024
- Addex Pharma SA
- Jean-Laurent Paparin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)
- Publication number 20240294475
- Publication date Sep 5, 2024
- Morphic Therapeutic, Inc.
- Matthew G. Bursavich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMPOUND
- Publication number 20240217968
- Publication date Jul 4, 2024
- DUKE STREET BIO LIMITED
- Phillip Martin Cowley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR PREPARING PYRIDAZINONE DERIVATIVES
- Publication number 20240051925
- Publication date Feb 15, 2024
- Madrigal Pharmaceuticals, Inc.
- Pasquale N. CONFALONE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20230357162
- Publication date Nov 9, 2023
- Denali Therapeutics Inc.
- Alex L. Bagdasarian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OLAPARIB OXALIC ACID COCRYSTALS AND THEIR PHARMACEUTICAL USE
- Publication number 20230322686
- Publication date Oct 12, 2023
- NUFORMIX TECHNOLOGIES LIMITED
- Joanne HOLLAND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN...
- Publication number 20230312481
- Publication date Oct 5, 2023
- ARBUTUS BIOPHARMA CORPORATION
- Andrew G. Cole
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS
- Publication number 20230202989
- Publication date Jun 29, 2023
- Janssen Pharmaceutica N.V.
- Michael Eric MURATORE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OLAPARIB HYDROXYBENZOIC ACID COCRYSTALS AND THEIR PHARMACEUTICAL USE
- Publication number 20230183185
- Publication date Jun 15, 2023
- NUFROMIX TECHNOLOGIES LIMITED
- Joanne HOLLAND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL PHTHALAZINE DERIVATIVE HAVING ECTONUCLOEOTIDE PYROPHOSPHATASE...
- Publication number 20230159469
- Publication date May 25, 2023
- TXINNO BIOSCIENCE INC.
- Seo Jung Han
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MTA-Cooperative PRMT5 Inhibitors
- Publication number 20230054883
- Publication date Feb 23, 2023
- Mirati Therapeutics, Inc.
- Thomas P. Bobinski
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETEROCYCLIC COMPOUND
- Publication number 20230042358
- Publication date Feb 9, 2023
- Takeda Pharmaceutical Company Limited
- Yuhei MIYANOHANA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHTHALAZINONE DERIVATIVES
- Publication number 20230015617
- Publication date Jan 19, 2023
- KuDOS Pharmaceuticals Limited
- Niall Morrison Barr Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)
- Publication number 20220340529
- Publication date Oct 27, 2022
- Morphic Therapeutic, Inc.
- Matthew G. Bursavich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ARYL SULFONAMIDES AS SMALL MOLECULE STAT3 INHIBITORS
- Publication number 20220289720
- Publication date Sep 15, 2022
- James TURKSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHTHALAZINONE COMPOUNDS AND USE THEREOF
- Publication number 20220235011
- Publication date Jul 28, 2022
- ST PHARM CO., LTD.
- Kyungjin KIM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SMALL MOLECULE INHIBITORS OF THE BFRB:BFD INTERACTION
- Publication number 20220031661
- Publication date Feb 3, 2022
- University of Kansas
- Mario RIVERA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RADIOLABELLED COMPOUND
- Publication number 20210284613
- Publication date Sep 16, 2021
- Oxford University Innovation Limited
- Veronique GOUVERNEUR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF IRES-MEDIATED PROTEIN SYNTHESIS
- Publication number 20210220331
- Publication date Jul 22, 2021
- The Regents of the University of California
- Joseph F. Gera
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS
- Publication number 20210214316
- Publication date Jul 15, 2021
- NUVATION BIO INC.
- Son Minh Pham
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MTA-Cooperative PRMT5 Inhibitors
- Publication number 20210079003
- Publication date Mar 18, 2021
- Mirati Therapeutics, Inc.
- Thomas P. Bobinski
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MTA-Cooperative PRMT5 Inhibitors
- Publication number 20210078994
- Publication date Mar 18, 2021
- Mirati Therapeutics, Inc.
- Thomas P. Bobinski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR SOLUBILIZING 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE
- Publication number 20210061771
- Publication date Mar 4, 2021
- Metriopharm AG
- Ingo Saar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LOW AFFINITY POLY(AD-RIBOSE) POLYMERASE 1 DEPENDENT CYTOTOXIC AGENTS
- Publication number 20200407374
- Publication date Dec 31, 2020
- The Trustees of the University of Pennsylvania
- Robert H. MACH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LABILE ESTERS OF AGROCHEMICALS FOR CONTROLLED RELEASE AND REDUCTION...
- Publication number 20200392063
- Publication date Dec 17, 2020
- Monsanto Technology LLC
- David A. Morgenstern
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)
- Publication number 20200385352
- Publication date Dec 10, 2020
- Morphic Therapeutic, Inc.
- Matthew G. Bursavich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR PRODUCING A CRYSTALLINE FORM OF 5-AMINO-2,3-DIHYDROPHTHA...
- Publication number 20200369623
- Publication date Nov 26, 2020
- Metriopharm AG
- Thomas MARTIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORM OF 5-AMINO-2, 3-DIHYDROPHTHALAZINE-1, 4-DIONE
- Publication number 20200369624
- Publication date Nov 26, 2020
- Metriopharm AG
- Thomas MARTIN
- C07 - ORGANIC CHEMISTRY

with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione

Heterocyclic compound

Olaparib hydroxybenzoic acid cocrystals and their pharmaceutical use

Olaparib oxalic acid cocrystals and their pharmaceutical use

Anti-cancer nuclear hormone receptor-targeting compounds

Low affinity poly(AD-ribose) polymerase 1 dependent cytotoxic agents

MTA-cooperative PRMT5 inhibitors

MTA-cooperative PRMT5 inhibitors

Labile esters of agrochemicals for controlled release and reduction...

Pyridinones and isoquinolinones as inhibitors of the bromodomain BRD9

Methhod for producing a crystalline form of 5-amino-2,3-dihydrophth...

Antagonists of human integrin (α4)(β7)

Phthalazinone derivatives

Method for measuring tyrosine phosphatase and tyrosine kinase activity

Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione

PRMT5 inhibitors

Phthalazinone compounds and methods for the treatment of cystic fib...

Labile esters of agrochemicals for controlled release and reduction...

Antagonists of human integrin α4β7

Crystalline form of olaparib and a process for preparing the same

Polyhydroxyphthalazinone compound, preparation method thereof and u...

Radiohalide-labeled targeted diagnostics and therapeutics

Cardiac troponin I ultra-sensitive detection reagent kit, and ultra...

Phthalazinone derivatives

Phthalazinones and isoquinolinones as rock inhibitors

Pyridazinone compounds and methods for the treatment of cystic fibr...

Inhibitor compounds of phosphodiesterase type 10A

Phthalazinone compounds and methods for the treatment of cystic fib...

Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium...

2,4-dioxo-quinazoline-6-sulfonamide derivatives as inhibitors of PARG

Patents Applicationslast 30 patents

PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE

PROCESS FOR THE PREPARATION OF OLAPARIB, AND CRYSTALLINE FORM THEREOF

SUBSTITUTED HETEROBICYCLIC DERIVATIVES AS NEGATIVE ALLOSTERIC MODUL...

ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)

PHARMACEUTICAL COMPOUND

METHODS FOR PREPARING PYRIDAZINONE DERIVATIVES

COMPOUNDS, COMPOSITIONS AND METHODS

OLAPARIB OXALIC ACID COCRYSTALS AND THEIR PHARMACEUTICAL USE

SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN...

COMPOUNDS

OLAPARIB HYDROXYBENZOIC ACID COCRYSTALS AND THEIR PHARMACEUTICAL USE

NOVEL PHTHALAZINE DERIVATIVE HAVING ECTONUCLOEOTIDE PYROPHOSPHATASE...

MTA-Cooperative PRMT5 Inhibitors

HETEROCYCLIC COMPOUND

PHTHALAZINONE DERIVATIVES

ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)

ARYL SULFONAMIDES AS SMALL MOLECULE STAT3 INHIBITORS

PHTHALAZINONE COMPOUNDS AND USE THEREOF

SMALL MOLECULE INHIBITORS OF THE BFRB:BFD INTERACTION

RADIOLABELLED COMPOUND

INHIBITORS OF IRES-MEDIATED PROTEIN SYNTHESIS

ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS

MTA-Cooperative PRMT5 Inhibitors

MTA-Cooperative PRMT5 Inhibitors

METHOD FOR SOLUBILIZING 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE

LOW AFFINITY POLY(AD-RIBOSE) POLYMERASE 1 DEPENDENT CYTOTOXIC AGENTS

LABILE ESTERS OF AGROCHEMICALS FOR CONTROLLED RELEASE AND REDUCTION...

ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)

METHOD FOR PRODUCING A CRYSTALLINE FORM OF 5-AMINO-2,3-DIHYDROPHTHA...

CRYSTALLINE FORM OF 5-AMINO-2, 3-DIHYDROPHTHALAZINE-1, 4-DIONE